The Hypertension Excellence Centre programme of the European Society of Hypertension – current status, activities and reshaping for the future
2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes
USING A CUMULATIVE LOW-DENSITY LIPOPROTEIN CHOLESTEROL MODELLING APPROACH TO ESTIMATE THE REDUCTION OF RISK OF ATHEROSCLEROTIC CARDIOVASCULAR EVENTS FROM A PRIMARY PREVENTION PROGRAM
Uut südamehaiguste ennetamises diabeetikutel Euroopa Kardioloogide Seltsi 2023. aasta ravijuhendis
Nutraceutical approaches to non-alcoholic fatty liver disease (NAFLD): A position paper from the International Lipid Expert Panel (ILEP)
ELMÜ laboratoorse hematoloogia töörühma soovitused hemogrammi laste referentsväärtuste harmoneerimiseks
Hirudin as the anticoagulant of choice for whole blood aggregometry
Comparison of chromogenic STA-R Evolution and CS-2500 assays for
Apixaban, Rivaroxaban and Dabigatran
Analysis of factor VIII levels in haemophilia A treated patients –
preliminary results of pharmacokinetic study
Cognitive disorders in patients with chronic kidney disease: specificities of clinical assessment
Effectiveness and feasibility of cardiovascular disease personalised prevention on high polygenic risk score subjects: a randomised controlled pilot study
Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab
Long-term stability of resting state EEG-based linear and nonlinear measures
Global perspective of familial hypercholesterolaemia: a cross sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC)